Mainboard · BSE and NSEListed

Paras Healthcare Limited IPO: dates, price band, lot size, objects of the issue

Get analyst updates on this IPO

Analyst updates come by email.

What changed since listing, from SEBI-registered research analysts.

By continuing you agree to the Terms and Privacy policy

Updated Mon 16 Nov 2026, 12:12 pm IST · Source: Basis of allotment dated Wed 28 Oct 2026

Bid dates
Wed 21 Oct 2026 to Fri 23 Oct 2026
Listing date
Wed 28 Oct 2026
Issue price
₹693 per share

Listed on BSE and NSE on Wed 28 Oct 2026.

Listing price ₹720

Opening price on BSE on the listing day (BSE daily price file for Wed 28 Oct 2026)

This page is now frozen. Facts stay as filed; the quote is on the exchange.

Key facts

Issue price
₹693 per share
Prospectus dated Fri 23 Oct 2026, page 3
Lot size
Not stated in the prospectus
Prospectus dated Fri 23 Oct 2026
Lot amount at the upper band
Not stated in the prospectus
Prospectus dated Fri 23 Oct 2026
Issue size at the upper band
₹1,450.00 crore
Fresh issue
₹500.00 crore
Prospectus dated Fri 23 Oct 2026, page 83
Offer for sale
₹950.00 crore
Prospectus dated Fri 23 Oct 2026, page 83
Bid dates
Wed 21 Oct 2026 to Fri 23 Oct 2026
Prospectus dated Fri 23 Oct 2026, page 2
Listing date
Wed 28 Oct 2026
BSE daily price file for Wed 28 Oct 2026
Anchor lock-in ends
Not stated in the prospectus
Prospectus dated Fri 23 Oct 2026
Risk factors
79
Prospectus dated Fri 23 Oct 2026, page 82

Timeline (IST)

  1. OpensWed 21 Oct 2026, 10:00 am IST confirmedProspectus dated Fri 23 Oct 2026, page 2
  2. ClosesFri 23 Oct 2026 confirmedProspectus dated Fri 23 Oct 2026, page 2
  3. UPI mandate cut-offNot stated in the prospectus Prospectus dated Fri 23 Oct 2026
  4. AllotmentMon 26 Oct 2026 by T+3 schedule
  5. Refund and unblockTue 27 Oct 2026 by T+3 schedule
  6. Shares to dematTue 27 Oct 2026 by T+3 schedule
  7. ListingWed 28 Oct 2026 confirmedBSE daily price file for Wed 28 Oct 2026

Objects of the issue

ObjectAmount
Prepayment or scheduled re-payment, in full or part, of certain outstanding borrowings availed by our Company₹320.90 crore
Investment in our wholly owned Subsidiary, PMHPL (which also operates our hospital in Srinagar), for repayment/prepayment of borrowings, in full or part, of PMHPL₹54.10 crore
General corporate purposes#₹101.11 crore
Total₹476.11 crore

The ₹950.00 crore offer for sale goes to the selling shareholders, not the company. Prospectus dated Fri 23 Oct 2026, page 129

Company and promoters

As described in the prospectus

We are a clinical specialty-led hospital platform providing tertiary and quaternary healthcare services through a network of eight hospitals with an aggregate bed capacity of 2,211 beds as of June 30, 2026 across North India, Bihar and Jharkhand.

Prospectus dated Fri 23 Oct 2026, page 258

Promoters

  • 1 individual promoter

Prospectus dated Fri 23 Oct 2026, page 359

Shareholding

HoldingBefore the issueAfter the issue
Promoters and promoter group72.80%Not stated in the prospectus
Public27.2%Not stated in the prospectus

Prospectus dated Fri 23 Oct 2026, page 119

Financials (restated)

ItemFor the three months period ended June 30, 2026For the three months period ended June 30, 2025For the year ended March 31, 2026For the year ended March 31, 2025For the year ended March 31, 2024
Revenue from operations₹470.28 crore₹368.39 crore₹1,605.95 crore₹1,294.06 crore₹1,129.04 crore
Profit after tax₹49.68 crore-₹1.02 crore₹43.83 crore-₹57.98 crore-₹15.33 crore
Net worth₹444.96 crore₹348.68 crore₹394.94 crore₹280.49 crore₹338.51 crore
Total borrowingsNot stated in the prospectusNot stated in the prospectusNot stated in the prospectusNot stated in the prospectusNot stated in the prospectus

Prospectus dated Fri 23 Oct 2026, page 88

Who is selling in the offer for sale

Selling shareholderTypeShares offeredAmount at the upper band
Individual shareholderIndividual43,29,004Not stated in the prospectus
Commelina LtdCompany93,79,509Not stated in the prospectus
Total offer for sale₹950.00 crore

Prospectus dated Fri 23 Oct 2026, page 83

Risk factors

79 total
  1. The company made losses in the June 2025 quarter and in Fiscals 2025 and 2024, and may not stay profitable (offer document page 26)
  2. Two subsidiaries running the Ranchi and Srinagar hospitals have made losses and may not turn profitable (offer document page 27)
  3. The business depends on doctors, nurses and staff, and staff attrition has been high (offer document page 27)
  4. Most revenue comes from five hospitals in North India, so regional problems could hurt results (offer document page 30)
  5. Revenue relies heavily on a few specialties such as cardiac, oncology and neuro sciences (offer document page 31)

All 79 risk factors, pages 26 to 82

Offer document

Allotment and bids

Registrar to the issue: MUFG Intime India Private Limited (formerly Link Intime India Private Limited).

Allotment status was expected on the registrar's site from Mon 26 Oct 2026 and is not yet confirmed. Pick "Paras Healthcare Limited" from the issue list there.

Subscription (final)

CategoryShares offeredShares bid forTimes subscribed
Retail Individual Investors20,92,35244,87,4482.14×
Non Institutional Investors - More than 2 Lakhs Upto 10 Lakhs10,46,1768,82,7140.84×
Non Institutional Investors - Above 10 Lakhs20,92,35212,95,6790.62×
Qualified Institutional Bidders62,77,0562,03,75,4603.25×
Anchor Investors94,15,58498,48,4751.05×
Total1,15,07,9362,70,41,3012.35×

Total: Excluding anchor investors

Basis of allotment dated Wed 28 Oct 2026, page 2

Research

Research reports on IPOs from SEBI-registered research analysts, published on InsightPier.

Research reports on IPOs from SEBI-registered research analysts